1. Background {#sec0005}
=============

Over recent years, the development of multiplex molecular biology techniques has enabled the rapid detection of respiratory viruses in many different contexts. Indeed, the rapid identification of respiratory pathogens has modified and improved the preventive and curative management of patients. It has been clearly shown that the rapid, accurate identification of respiratory specimens can have a significant impact on disease progression; this enables the introduction of appropriate therapy, decreases the unnecessary use of antimicrobial agents, and thus limits the risk of secondary infections in medical establishments \[[@bib0005]\]. These multiplex techniques have supplanted traditional methods for the diagnosis of respiratory tract infections (such as cultures, direct fluorescent-antibody staining, and enzyme immunoassays) and are superior in terms of sensitivity, execution time and turn-around time \[[@bib0010]\]. Lastly, multiplex molecular biology techniques can also be rapidly adapted to detect new or emerging viruses. Although the reagent cost is inherently higher, many studies have clearly demonstrated that appropriately prescribed respiratory multiplex assays are cost-effective and can generate significant savings for hospitals \[[@bib0015], [@bib0020], [@bib0025]\].

The diagnostic spectrum varies from one commercial kit to another, although all kits detect the main pathogens: influenzavirus A (InfA), influenzavirus B (InfB), human respiratory syncytial virus (hRSV), human metapneumovirus (hMPV), enterovirus (EV), human rhinovirus (hRV), parainfluenzaviruses (PIVs), adenoviruses (AdVs), human bocavirus (hBoV), and human coronaviruses (229E, NL63, OC43, HKU1; hCoVs).

For all these reasons, the use of multiplex molecular assays has increased the detection of viral respiratory infections and co-infections. Although earlier estimates of viral coinfection (based on culture, serology and certain molecular methods) yielded a frequency of around 10% \[[@bib0030]\], values of up to 44% in young children have recently been determined with PCR assays \[[@bib0035], [@bib0040]\].

The primary objective of the present study was to assess the epidemiology and seasonality of viral respiratory infections in hospitalized children. In this context, we analysed the results of a routine, multiplex PCR assay (xTAG Respiratory Viral Panel Fast assay, Luminex Molecular Diagnostics) for respiratory viruses gathered over four consecutive years (from September 2012 to August 2016), and thus investigated the seasonal and year-to-year prevalences of the viruses most commonly responsible for respiratory infections and coinfections.

2. Study design {#sec0010}
===============

2.1. Patients and specimens {#sec0015}
---------------------------

We performed a single-centre, retrospective study of children (under the age of 16) admitted to Amiens University Hospital (Amiens, France) for an acute respiratory illness. In accordance with local guidelines, a multiplex PCR assay for respiratory viruses was used to screen nasopharyngeal swabs or aspirates at time of respiratory symptoms. The samples were collected from 3199 patients between September 2012 and August 2016. All specimens were stored at −70 °C after testing.

2.2. Respiratory virus testing {#sec0020}
------------------------------

Nasopharyngeal swabs or aspirates were extracted using the NucliSENS^®^ easyMAG^®^ technique (bioMérieux, Craponne, France). Before extraction, an internal positive control (*Escherichia coli* phage MS2, provided by the manufacturer) was added to the samples. The extracts were screened with the xTAG Respiratory Viral Panel Fast assay (Luminex Molecular Diagnostics Inc., Toronto, Canada), according to the manufacturer's instructions. An aliquot of each extract was stored at −70 °C. A positive run control (bacteriophage lambda DNA) was used in each run to monitor assay performance. The resulting median fluorescence intensities (MFIs) were analysed the Luminex 100 IS system and TDAS RVP Fast software (version 2.00, Luminex). The assay can detect 18 different respiratory viruses: InfA H1N1 and H3N2, InfB, hRSV, hMPV, EV/hRV, PIV types 1, 2, 3 and 4, AdV, hBoV, and hCoVs 229E, NL63, OC43 and HKU1.

2.3. Weather variables {#sec0025}
----------------------

Retrospective temperature data were obtained from Météo France, the French state meteorological office (http://www.meteofrance.com/climat/france/abbeville/80001001/releves).

2.4. Statistical analysis {#sec0030}
-------------------------

A non-parametric Mann--Whitney test was applied to continuous variables, and a chi-squared test or Fisher's exact test was applied to categorical variables. The threshold for statistical significance (two-tailed) was set to p ≤ 0.05 was considered.

2.5. Ethics statement {#sec0035}
---------------------

We performed out a non-interventional study; no additional diagnostic, monitoring or treatment procedures were applied to routine patient care. Data were analysed after they had been anonymized. In line with the French legislation on clinical studies, this type of trial does not require approval by an independent ethics committee or the provision of informed consent by the participants.

3. Results {#sec0040}
==========

3.1. The distribution of respiratory viruses as a function of the patient's age {#sec0045}
-------------------------------------------------------------------------------

In total, 3199 samples (received from September 2012 to August 2016) were analysed. Of these, 1575 (49.2%) were negative for all 18 respiratory viruses, whereas 1624 (50.8%) were positive for at least one respiratory virus. The total numbers of positive samples were as follows: 72 for InfA, 72 for InfB, 192 for PIV, 237 for hRSV, 891 for ER/hRV, 100 for AdV, 120 for hBoV, 116 for hCoV, and 87 for hMPV.

As shown in [Table 1](#tbl0005){ref-type="table"} , the viral profile varied with age. Some viruses were significantly more frequent in children under the age of 1 month (such as hRSV (p \< 0.0001)), whereas others were significantly more frequent in children over that age (such as InfA/InfB (p \< 0.0001) and AdVs (p = .0006)). The respective frequencies of other viruses (such as the hCoV, hMPV, PIVs, and ER/hRV) did not vary with the patient's age.Table 1Proportion of positive samples in each age group for each virus, in samples from 2012 to 2016.Table 1Patient age group (N = total number)Number of samplesPercentage of positive samplesNegativePositive for at least one virus (%)Inf AInf BPIVhRSVER&hRVAdVhBoVhCoVhMPV\< 1 month (N = 602)387215 (35.7%)3.77%1.67%9.21%21.34%52.72%1.67%1.26%5.02%3.35%1--24 months (N = 1477)651826 (55.9%)2.71%2.21%11.46%13.87%46.03%4.62%6.73%7.44%4.92%\>24 months (N = 1120)537583 (52.0%)5.51%7.04%8.58%7.35%47.01%7.66%7.66%4.59%4.59%

Multiplex molecular assays are valuable because they enable the simultaneous detection of several different viruses in the same sample, and can therefore reveal the presence of coinfections. Here, 210 samples (13.3%) were positive for two different viruses, 28 (1.7%) were positive for three, and 3 (0.2%) were positive for four. The percentage of patients with a coinfection differed significantly as a function of age (p \< 0.0001): 9.5% for children younger than 1 month, 63.7% for children aged between 1 and 24 months, and 26.8% for children aged over 24 months. The viral profile in coinfections ([Fig. 1](#fig0005){ref-type="fig"} ) highlighted the predominance of EV/hRV. Indeed, EV/hRV was found in 161 (76.6%) of the 210 coinfections with two viruses, in 25 of the 28 (89.3%) coinfections with three viruses, and 3 of the 3 (100%) infections with four viruses. The viruses most frequently detected with EV/hRV were the PIV types 1--4 (17.1%), followed by hRSV (15.7%), AdV (14.3%), hBoV (11.4%), hCoVs (7.1%), and hMPV (7.6%).Fig. 1A schematic representation of the frequency of viruses detected in co-infections, expressed as a percentage of the 210 documented co-infections. The degree of shading corresponds to the frequency of each co-infection. Note that the data are mirrored about the diagonal.Abbreviations: Inf: influenzavirus; hRSV: human respiratory syncytial virus; hMPV: human metapneumovirus; EV&hRV: enterovirus/rhinovirus; PIV: parainfluenzaviruses; AdV: adenoviruses; hBoV: human bocavirus; hCoV: human coronavirusesFig. 1

In the absence of EV/hRV, the most frequently observed association was hRSV and hCoVs (3.3%). Conversely, some associations were never observed (e.g. InfB with hRSV, PIV or hCoVs, and InfA with hMPV).

3.2. Changes in the viral distribution profile over time {#sec0050}
--------------------------------------------------------

This retrospective study was performed over 4 consecutive years (September 2012 to August 2016), making it possible to study the seasonal and year-to-year distribution of various viruses in a region with an oceanic, temperate climate.

Unsurprisingly for the northern hemisphere, the number of assays performed was higher in winter than in summer ([Table 2](#tbl0010){ref-type="table"} ). The percentage of positive assays was highest in autumn (mid September to mid December) (55%), followed by winter (mid December to mid March) (53.6%), spring (mid March to mid June) (50.5%) and summer (mid June to mid December) (39.5%). The number of viral co-infections was highest in winter (18.3%), followed by spring (15.8%), autumn (11.7%) and summer (11.6%).Table 2Proportion of positive samples for each season, from 2012 to 2016.Table 2SeasonAutumnWinterSpringSummerNumber of samples per season (mean ± SD)208.8 ± 72.9250.3 ± 85.5194.0 ± 39.5146.8 ± 46.8Number of positive samples per season (mean ± SD)115 ± 38.8134.0 ± 37.798.5 ± 41.158.5 ± 22.1Percentage of positive samples55.053.650.539.5Percentage of co-infections11.718.315.811.6

Furthermore, the seasonal distribution profile varied for some species but not others. As shown in [Fig. 2](#fig0010){ref-type="fig"} , EV and hRV were predominant throughout the year. Similarly, AdVs were not linked to a particular season and were isolated throughout the year. In contrast, hRSV preferentially infected children in winter, despite a higher number of positive assays in November each year. Although the frequency of influenza viruses was relatively low in our study population, the highest values were observed in the coldest months (from January to March).Fig. 2Circulation of respiratory viruses over the four seasons, as a function of the month\'s mean atmospheric temperature. The bars represent the number of positive cases (left y axis). The dashed grey line represents the month\'s mean atmospheric temperature degree in degree Celsius, °C (right y axis).Abbreviations: Inf: influenzavirus; hRSV: human respiratory syncytial virus; hMPV: human metapneumovirus; EV&hRV: enterovirus/rhinovirus; PIV: parainfluenzaviruses; AdV: adenoviruses; hBoV: human bocavirus; hCoV: human coronavirusesFig. 2

Adenoviruses, hMPV, hCoVs and hBoV were less frequently detected. Human coronaviruses were mainly observed from October to April. The hMPVs were rare but were predominantly detected in the winter. The hBoV was distributed broadly between February and May. Parainfluenzaviruses could be detected throughout the year but were not observed in children during the winters of 2014, 2015 and 2016. However, temperature is rarely a limiting factor in the circulation of respiratory viruses. As indicated in [Table 3](#tbl0015){ref-type="table"} , only the frequency of influenza viruses appeared to be significantly associated with temperatures below 10 °C (p = .0002).Table 3Proportion of positive samples in each atmospheric temperature group over the period 2012--2016, for each virus.Table 3Temperature in degrees Celsius (degrees Fahrenheit)Number of months in the group/Total number of monthsNumber of positive assaysMean \[95%IC\]InfPIVhRSVER/hRVAdVhBoVhCoVhMPV\<10 °C (50 °F)15/485177.06 \[2.72--11.41\]2.46 \[0.30--4.63\]5.00 \[2.54--7.45\]12.07 \[8.19--15.93\]1.13 \[0.72--1.54\]1.53 \[0.17--2.88\]3.86 \[2.48--5.25\]1.33 \[0.61--2.04\]10--20 °C (50--68 °F)23/486950.47 \[0.13--0.82\]2.87 \[1.75--3.98\]4.34 \[1.25--7.44\]18.57 \[14.89--22.24\]0.73 \[0.19--1.28\]1.43 \[0.61--2.25\]0.65 \[0.26--1.03\]1.13 \[0.47--1.78\]\>20 °C (68 °F)10/481700.10 \[0.12--0.32\]2.87 \[1.75--3.98\]0.30 \[0.18--0.78\]9.90 \[5.47--14.33\]1.30 \[0.08--2.60\]1.00 \[0.04--1.95\]0.30 \[0.18--0.78\]1.40 \[0.12--2.67\]*p*0.0002NSNSNSNSNSNSNS[^1]

4. Discussion {#sec0055}
=============

The application of new multiplex PCR assays has provided new insights into the epidemiology of viral respiratory infections in children and adults \[[@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065]\]. However, some situations have yet to be characterized. Indeed, the results of our retrospective study (carried out over 4 consecutive years in hospitalized children aged under 16) showed that only 50.8% of the samples were positive for at least one respiratory virus; this agrees with the report by Tanner et al. \[[@bib0070]\]. Although all the patients were symptomatic, only half of them had an etiologic diagnosis. The remaining infections may be caused by bacteria or viruses not screened for by standard panels. A number of new respiratory viruses have been identified over the last 25 years; these include the hMPV (discovered by Van Den Hoogen et al. in 2001), the hBoV (discovered by Allander et al. in 2005) and the Middle East respiratory syndrome CoV (discovered by Berminghan et al. in 2012) \[[@bib0075], [@bib0080], [@bib0085]\]. It is probable that other respiratory viruses will yet be discovered and will have to be taken into account via the development of new screening assays.

Hence, with a view to increasing the proportion of lower and upper respiratory tract infections with an etiologic diagnosis, it is important to expand the syndromic respiratory approach to include other pathogens.

Our present results emphasized the great variations in the positivity rate and viral distribution from one age group to another, and confirmed some of previous observations made in France \[[@bib0050]\] whereby very young children (under the age of 1 month) had lower positivity and viral coinfection rates than older children. However, the picornaviruses (EVs/hRVs) were most frequent in all age groups. The distribution did not vary greatly with age. In children under 1 month and in those aged between 1 and 24 months, the second and third most frequently detected viruses were hRSV and PIVs, respectively. This ranking differed in children aged over 24 months, where Inf viruses were most frequent and hRSV was the second most frequent type. The high frequency of hRSV infection in infants under the age of 6 months of age has been clearly documented in several studies \[[@bib0090]\]. Our present results confirm the importance of screening for hRSV in very young children. However, the high proportion of picornaviruses isolated alone or as co-infection in symptomatic children raises the question of their true pathogenicity; further studies are therefore required.

Lastly, the impact of seasonal temperature changes on the circulation of respiratory viruses appears to be very moderate. Indeed, most non-enveloped viruses are not influenced by higher temperatures and can survive deviations of 20 °C. However, some enveloped viruses (such as the influenza virus) appeared to be restricted by temperatures over 20 °C. It is possible that the increases in atmospheric temperature associated with global warming may modify the viral distribution profile--especially for non-enveloped viruses.

In conclusion, the present study provided a broad description of the distribution of respiratory viruses among hospitalized children over four consecutive years. Our results highlighted the persistence of non-enveloped viruses and certain enveloped viruses throughout the year--regardless of the temperature variations that may cause respiratory damage.
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